All News
|
Media Advisory
Study shows treatment does no harm, but provides no benefit What A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has been stopped by the National Institutes of Health. A data and safety monitoring board (DSMB) met late Friday and...
|
NHLBI in the Press
Researchers are reporting in laboratory studies that the anti-cholesterol drug lovastatin shows promise as a potential treatment for a common form of dilated cardiomyopathy, or enlargement of the heart.
|
NHLBI in the Press
Stroke patients in rural areas are less likely to get the most advanced medical treatments and are more likely to die before leaving the hospital than those treated in urban areas.
|
NHLBI in the Press
Most donor lungs are not suitable for transplantation, but a new technique that uses pigs could revitalize many of those lungs and increase the transplant supply, according to NHLBI-funded research published in Nature Medicine.
|
NHLBI in the Press
Insufficient REM sleep appears to be associated with a higher risk of death among middle-aged and older adults, according to a new study.
|
NHLBI in the Press
A multidisciplinary team of researchers uncovered a potential mechanism that could explain the abnormal blood clotting encountered in COVID-19 patients and a biomarker that may aid the treatment of patients.